PharmaBoardroom

The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year.…

You are by far the largest Convention Centre in Chile. When was it decided to construct such an impressive event area and what was the vision behind…

In 2012 Servier China became the 3rd largest affiliate within the Servier group. How has the company progressed since then? Servier-China is a…

In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the…

Since this interview, Michael Ryde has left Lundbeck China and is now working as Commercial Counsellor, Teamleader Health, at the Danish Embassy in…

Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission…

For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of…

Mr. Medda, Teva’s Italian history is relatively young, could you describe the main facts that describe Teva presence in Italy? Teva Italia was…

Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and…

With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases.…

Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland…

In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all…